L. Irestedt et al., ROPIVACAINE 7.5 MG ML FOR ELECTIVE CESAREAN-SECTION - A CLINICAL AND PHARMACOKINETIC COMPARISON OF 150 MG AND 187.5 MG/, Acta anaesthesiologica Scandinavica, 41(9), 1997, pp. 1149-1156
Background: The new, long-acting local anaesthetic ropivacaine has sho
wn less systemic toxicity than bupivacaine and a concentration of 7.5
mg/ml can therefore be used for epidural anaesthesia in Caesarean sect
ion. The present pilot study was undertaken to find indications for an
optimal dosage by comparing the clinical effects, quality of anaesthe
sia and pharmacokinetics of ropivacaine 150 mg (lower dose=LD) vs 187.
5 mg (higher dose=HD) for women undergoing elective Caesarean section
under epidural anaesthesia. Methods: Sixteen full-term women scheduled
for elective Caesarean section in two equal-sized consecutive groups
received 20 or 25 ml ropivacaine epidurally in this non-randomised, op
en study. Study parameters included sensory and motor blockade, circul
atory response, intraoperative pain and discomfort, neonatal evaluatio
n and pharmacokinetic determinations. Results: Block height varied bet
ween T5 and T2 in the LD group, whereas the HD group produced 4 unnece
ssarily high blocks (C8 in 3 women and C7 in 1 woman). Surgical anaest
hesia was excellent in both groups. Circulatory stability was pronounc
ed in the LD group (no ephedrine given), while 4 women required ephedr
ine in the HD group. Neonatal outcome as judged by Apgar scores, umbil
ical blood gas determinations and NACS scores were excellent in both g
roups. The plasma concentration-time profiles indicated linearity in t
he concentration range studied, with similar clearance values to those
reported previously. Placental drug equilibrium was rapid; however, t
he foetal drug exposure depended on intrauterine exposure time. Conclu
sions: 20-25 ml ropivacaine 7.5 mg/ml produced very satisfactory condi
tions for elective Caesarean section under epidural anaesthesia. In th
is small population, 150 mg ropivacaine seemed optimal, while 187.5 mg
produced unnecessarily extended block height in 50% of the women. (C)
Acta Anaesthesiologica Scandinavica 41 (1997).